Pasar al contenido principal

TRAZABILIDAD DE LA PRESENCIA DE ANTIBIOTICOS EN LECHE, QUESO Y LACTOSUERO DE CABRA

AGL2013-45147-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2013
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario UNIVERSITAT POLITÈCNICA DE VALÈNCIA
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 14
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Antibiotic residues in milk and cheeses after the off-label use of macrolides in dairy goats

  • Quintanilla-Vázquez, Paloma Galicia
  • Beltrán Martínez, Mª Carmen|||0000-0002-5335-2179
  • Peris Palau, Bernardo
  • Rodríguez Garcia, Martín|||0000-0001-6079-9238
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
[EN] The limited availability of drugs registered for dairy goats makes veterinarians prescribe off-label treatments with a legally established minimum safety period of seven days. The aim of this work was to verify if the exceptional use of macrolide antibiotics in dairy goats generates residues in milk and cheeses within that period. Hence, three macrolide drugs (erythromycin, tylosin and spiramycin) were administred in an in vivo experiment in dairy goats. Ripened cheeses were made from bulk milk obtained before drug administration, 24¿h after treatment, and at the end of the recommended withdrawal period. Residual amounts of erythromycin (234.9¿±¿52.7¿¿g/kg), tylosin (198.7¿±¿57.8¿¿g/kg) and spiramycin (1539.8¿±¿469.4¿¿g/kg), widely exceeding their legal maximum residue limits (MRLs) established, were detected in milk collected 24¿h after treatment, making the cheese production in most cases impossible. After the seven-day period, only spiramycin was detected in goat¿s milk (79.6¿±¿19.2¿¿g/kg) although no antibiotic residues were found in the cheeses. A withdrawal time of seven days seems suitable to guarantee milk safety after the administration of erythromycin and tylosin without any negative effects neither on the milk nor on the and cheese properties. However, given the rapid elimination of these substances, a shorter withdrawal period might be considered. For spiramycin, persisting in milk for a longer period, further studies on its pharmacokinetics in dairy goats would be recommendable to avoid a potential risk to consumer health., This work is part of the AGL-2013-45147-R funded by Ministerio de Ciencia e Innovacion (Madrid. Spain). The authors thank the 'Program of Support for Research and Development' (PAID-2014, UPV) for support P. Quintanilla PhD studies at Universitat Politecnica de Valencia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Influence of enrofloxacin on the coagulation time and the quality parameters of goat&apos, s milk yoghurt

  • Beltrán Martínez, Mª Carmen|||0000-0002-5335-2179
  • Escriche Roberto, Mª Isabel|||0000-0003-0180-0360
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
  • Morari-Pirlog, A.
  • Quintanilla-Vázquez, Paloma Galicia
[EN] Three batches of yoghurts were made from goat s milk with different enrofloxacin concentrations (0, 50, 100 and 150 lg/kg). Quality parameters were analysed at 1, 7, 14 and 28 days at 5 °C. Drug residues were also quantified by HPLC. Coagulation time and most yoghurt properties remained unaffected by the presence of enrofloxacin in goat s milk. However, quality parameters were affected by the storage period. 74.9 99.2% of enrofloxacin initially added to goat s milk remained in the yoghurt throughout its entire shelf life, potentially posing a risk to consumer health. Therefore, an enrofloxacin maximum residue limit in yoghurt should be established.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Characteristics of ripened Tronchon cheese from raw goat milk containing legally admissible amounts of antibiotics

  • Quintanilla-Vázquez, Paloma Galicia
  • Molina Casanova, A.M.
  • Beltrán Martínez, Mª Carmen|||0000-0002-5335-2179
  • Escriche Roberto, Mª Isabel|||0000-0003-0180-0360
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
[EN] The aim of this study was to evaluate the transfer of the most widely used antibiotics in dairy goats from milk to cheese as well as their effect on the cheese-making process and cheese characteristics during ripening. Antibiotic-free milk was spiked individually with 7 veterinary drugs (amoxicillin, benzylpenicillin, cloxacillin, erythromycin, ciprofloxacin, enrofloxacin, and oxytetracycline) at an equivalent concentration of the European Union maximum residue limit. Spiked goat milk was used to make mature Tronchon cheeses, which were analyzed at 0, 30, and 60 d of maturation to determine pH, chemical composition, proteolytic and lipolytic activities, and color and textural properties. A sensory evaluation of 60-d ripened cheeses was carried out. Cheeses from raw antibiotic-free goat milk were made simultaneously to be used as reference. The cheese-making process was unaffected by the presence of most antibiotics evaluated. Only erythromycin and oxytetracycline significantly increased the time required for cheese production (122 +/- 29 and 108 +/- 25 min, respectively). However, variable amounts of antibiotics, ranging from 7.4 to 68%, were transferred from milk to cheese, with oxytetracycline and quinolones showing the highest retention rates. In general, antibiotic residues present in the cheeses at the beginning of maturation decrease significantly along time. Thus, beta-lactams and erythromycin residues were not detectable after 30 d of ripening. However, relatively high concentrations of enrofloxacin (148 +/- 12 mu g/kg) and ciprofloxacin (253 +/- 24 mu g/kg) residues were found in the cheeses after 60 d of maturation. The quality characteristics of the Tronchon cheeses were only slightly affected by such substances, with few significant differences in the free fatty acid concentration and color and textural properties of the cheeses. Results herein indicate that the use of goat milk containing antibiotics, such as quinolones, at the European Union maximum residue limit for cheese production could adversely affect the safety of the final products because relatively high concentrations of these substances could be retained in soft and semi-mature cheeses, making it necessary to assess the risk for consumer health. Studies on the partition of the antibiotic substances during cheese-making, using specific technologies, would be convenient to guarantee the safety of cheese and related products., This work is part of the AGL-2013-45147-R Project funded by Ministerio de Ciencia e Innovación (Madrid, Spain). P. Quintanilla thanks Universitat Politècnica de València (Valencia, Spain) for the grant received for the development of this work (PAID-2014, UPV).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Transfer of antibiotics from goat&apos, s milk to cheese and whey, Transferencia de antibióticos de leche de cabra a queso y suero

  • Giraldo Gómez, Jennifer
[ES] La presencia de residuos de antibióticos en la leche y los productos derivados representa un riesgo para los consumidores. Límites Máximos de Residuos (LMRs) no se han fijado para los productos lácteos y la transferencia de antibióticos de la leche a la cuajada y al lactosuero durante el proceso de elaboración del queso apenas ha sido estudiada. El objetivo de esta tesis fue evaluar la transferencia de antibióticos de la leche al queso y lactosuero, así como la validación de las características de varios métodos de cribado para la detección de antibióticos en muestras de suero de leche. En el primer estudio, el objetivo fue validar un método UHPLC-HRMS multi-residuo utilizando el analizador Orbitrap ExactiveTM, para el cribado cuantitativo de antibióticos en muestras de leche, queso fresco y lactosuero de acuerdo con los criterios especificados en la Decisión 657/2002/CE de la Comisión. El estudio de distribución mediante el método UHPLC-HRMS indicó que la mayor parte de antibióticos se transfirieron principalmente de la leche a la fracción lactosuero (hasta el 85,9%) durante la elaboración de queso. Por tanto, los porcentajes de retención de antibióticos en la cuajada fueron inferiores al 50%, excepto en el caso del ceftiofur (59,7%) y la dicloxacilina (52,8%), y muy variables entre los distintos antimicrobianos. En la mayor parte de los casos, la distribución de medicamentos no se vio afectada por la concentración de antibióticos presente en la leche, y estuvo escasamente relacionada con la lipofilicidad de los antibióticos. En el segundo estudio, se evaluaron las características de diferentes métodos de detección de antibióticos en muestras de lactosuero de acuerdo con la Decisión 657/2002/CE de la Comisión. En primer lugar, la especificidad (porcentaje de falsos positivos) y la capacidad de detección (CCß) del método de detección de inhibidores Eclipse Farm provisto del dispositivo e-Reader y de los métodos de unión a receptores 3Aminosensor, Quinosensor, Twinsensor y Tylosensor se evaluaron en muestras de lactosuero de leche de cabras, obteniendo en general, resultados similares a los obtenidos cuando se aplican para el análisis de la leche. También se evaluaron tres bioensayos en placa microtiter y respuesta dicotómica, que contenían Bacillus subtilis, Geobacillus thermocatenulatus y Geobacillus thermoleovorans, respectivamente, para ser aplicados simultáneamente con los métodos comerciales basados en la utilización de Geobacillus. stearothermophilus var. calidolactis. Elevados valores de especificidad (98-100%) se obtuvieron cuando las muestras de lactosuero fueron tratadas térmicamente (85ºC, 10 min). Bacillus subtilis, con menores valores de CCß para quinolonas y macrólidos, fue la opción más interesante para mejorar el perfil de detección del Eclipse 100. En cuanto al sistema multiplaca Screening Test for Antibiotic Residues (STAR) que utiliza cinco microorganismos diferentes (Geobacillus stearothermophilus para betalactámicos y sulfonamidas, Bacillus subtilis para aminoglucósidos, Kocuria varians para macrólidos, Escherichia coli para quinolonas y Bacillus cereus para tetraciclinas) aplicado al lactosuero, presentó una elevada especificidad (>=98%) en la mayor parte de casos. Los valores de CCß obtenidos con el protocolo STAR en muestras de lactosuero superan el LMR establecido en la leche, aunque podría representar una adecuada herramienta en la etapa de post-cribado y reducir el número de muestras destinadas al análisis cuantitativo por LC-MS/MS. La producción de queso a partir de leche con antibióticos genera residuos en el lactosuero. Por tanto, adecuados métodos de cribado para la detección de residuos de antibióticos en este importante subproducto de la elaboración del queso permitirían el establecimiento de una apropiada estrategia de control para prevenir la presencia de antibióticos en el lactosuero y, así, evitar los posibles efectos, [CA] La presència de residus d'antibiòtics en la llet i els productes derivats representa un risc per a la salut del consumidor. Límits Màxims de Residus (LMRs) no s'han fixat per als productes lactis i la transferència d'antibiòtics de la llet al formatge i al sèrum durant el procés d'elaboració del formatge quasi no s'ha estudiat. L'objectiu d'aquesta tesi va ser avaluar la transferència d'antibiòtics de la llet a les fraccions formatge i sèrum, així com la validació de la resposta de diversos mètodes per a la detecció d'antibiòtics en mostres de sèrum de llet. En el primer estudi, l'objectiu va ser validar un mètode UHPLC-HRMS multi-residu utilitzant l'analitzador Orbitrap ExactiveTM, per al garbellat quantitatiu d'antibiòtics en mostres de llet, formatge fresc i sèrum, d'acord amb els criteris especificats en la Decisió 657/2002/CE de la Comissió. L'estudi de partició utilitzant UHPLC-HRMS mètode va indicar que la major part d'antibiòtics es van transferir principalment de la llet a la fracció sèrum de llet (fins al 85,9%) durant l'elaboració de formatge. Per tant, els percentatges de retenció d'antibiòtics en la quallada van ser inferiors al 50%, excepte en el cas del ceftiofur (59,7%) i la dicloxacilina (52,8%), i molt variables entre els diferents fàrmacs. En la majoria dels casos, la distribució de medicaments no es va veure afectada per la concentració d'antibiòtics present en la llet per a la producció de formatge, i va estar escassament relacionada amb la lipofilicitat dels antibiòtics. En el segon estudi, es van avaluar les característiques de diferents mètodes de detecció d'antibiòtics en mostres de sèrum d'acord amb la Decisió 657/2002/CE de la Comissió. L'especificitat (percentatge de falsos positius) i la capacitat de detecció (CCß) d'una prova d'inhibició microbiana (Eclipse Farm acoblat al dispositiu e-Reader) i d'assajos d'unió a receptors (3Aminosensor, Quinosensor, Twinsensor i Tylosensor) es van avaluar en mostres de sèrum de llet de cabra, obtenint en general, resultats similars als obtinguts quan s'apliquen per a l'anàlisi de la llet. Es van avaluar tres bioassatjos en placa microtiter i resposta dicotòmica, que contenien Bacillus subtilis, Geobacillus thermocatenulatus i Geobacillus thermoleovorans, respectivament, per a ser aplicats simultàniament amb els mètodes comercials basats en la utilització de Geobacillus stearothermophilus var. calidolactis. Elevats valors d'especificitat (98-100%) es van obtindre quan les mostres de sèrum van ser tractades tèrmicament (85°C, 10 min). Bacillus subtilis, amb menors valors de CCß per a quinolones i macròlids, va ser l'opció més interessant per a millorar el perfil de detecció del mètode Eclipse 100. Respecte al sistema multiplaca Screening Test for Antibiotic Residues (STAR) que utilitza cinc microorganismes diferents (Geobacillus stearothermophilus per a betalactàmics i sulfonamides, Bacillus subtilis per a aminoglucòsids, Kocuria varians per a macròlids, Escherichia coli per a quinolones i Bacillus cereus per a tetraciclines), va presentar una elevada especificitat (>=98%) en la major part de casos. Els valors de CCß obtinguts amb el protocol STAR en mostres de sèrum superen el LMR establit en llet. No obstant això, aquest mètode podria convertir-se en una eina adequada en el post-garbellament per a la identificació preliminar dels residus d'antibiòtics presents en el sèrum de llet i reduir el nombre de mostres destinades a l'anàlisi quantitativa per LC-MS/MS, que és un mètode més complex i car. La producció de formatge a partir de llet amb antibiòtics genera residus en el sèrum. L'adequada prestació dels mètodes de garbellat per a la detecció de residus d'antibiòtics en aquest subproducte d'elaboració del formatge permetria l'establiment d'una estratègia de control per a evitar el risc derivat de la presència d'aquestes substàncies en el sèrum, amb efectes negatius sobre la, [EN] The presence of antibiotic residues in milk and dairy products poses a risk for consumer health, mainly the development of antimicrobial resistance. Maximum Residue Limits (MRLs) for veterinary drugs have not been established for dairy products. Furthermore, the transfer of antibiotics from milk to cheese and whey fractions during cheese-making has been scarcely studied and, therefore, the impact of the use of whey containing antibiotics for the manufacture of foodstuffs for human and animal consumption is unknown. The aim of this thesis was to evaluate the transfer of antibiotics from milk to cheese and whey fractions, as well as the validation of the performance of several methods to screen antibiotics in whey samples. In the first study, a multiresidue UHPLC-HRMS method using the Orbitrap ExactiveTM analyser for the quantitative screening of antibiotics in milk, fresh cheese, and whey samples was validated according to Commission Decision 2002/657/EC, using samples from three different dairy matrices (milk, fresh cheese and whey) from cows, sheep and goats. The partitioning study by UHPLC-HRMS method indicated that most antibiotics were mainly transferred from milk to whey fraction (up to 85.9%) during cheese-making. Thus, retention rates in the rennet curd fraction were lower than 50%, except for ceftiofur (59.7%) and dicloxacillin (52.8%), and very variable between drugs. In most cases, drug distribution was unaffected by the antibiotic concentration present in milk for cheese production and was poorly related to the drug lipophilicity. In the second study, the performance of different methods for screening antibiotics in whey samples was evaluated in accordance with Commission Decision 2002/657/EC, by conducting three experiments focused on commercially available screening tests, microtiter plate bioassays, and a semi-quantitative multi-plate system, respectively. Specificity (false-positive rate) and Detection Capability (CCß) of a microbial inhibitor test (Eclipse Farm coupled to e-Reader device) and receptor-binding assays (3Aminosensor, Quinosensor, Twinsensor, and Tylosensor) were evaluated in whey samples from goats, having in general, similar results than those obtained when they are applied for milk analysis. Three microtiter plate bioassays with dichotomous response containing Bacillus subtilis, Geobacillus thermocatenulatus and Geobacillus thermoleovorans, respectively, were evaluated simultaneously with commercially available tests using Geobacillus stearothermophilus var calidolactis. High specificity values (>=98%) were obtained when whey samples were heat treated (85ºC, 10 min) prior to analysis. Bacillus subtilis, having lower CCß values for quinolones and macrolides, was the most interesting option to improve the detection profile of the Eclipse 100. Regarding the multiplate system Screening Test for Antibiotic Residues (STAR) using Geobacillus stearothermophilus for ß-lactams and sulfonamides, Bacillus subtilis for aminoglycosides, Kocuria varians for macrolides, Escherichia coli for quinolones and Bacillus cereus for tetracyclines, high specificity values (>=98%) were obtained in most cases. The CCß values obtained using the STAR protocol in whey samples exceed the MRL established in milk for most of the substances considered. However, this method could become an adequate tool in post-screening and reduce the number of samples destined for the quantitative analysis by LC-MS/MS, which is a more complex and expensive method. The production of cheese using milk containing antibiotics generates drug residues in whey. Thus, the suitable performance of screening methods for the detection of veterinary drug residues in this cheese-making by-product will allow the establishment of an adequate control strategy to prevent the presence of antibiotic residues in whey and to avoid the hazards associated to human and animal health and environment., This research forms part of the Project AGL-2013-45147-R financed by the Ministerio de Ciencia e Innovación
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Performance of Eclipse Farm test coupled with e-Reader for screening antibiotics in sheep ang goat&apos, s milk, Evaluation de la performance du test Eclipse Farm 3G couplé avec le lecteur e-Reader pour le dépistage d&apos, antimicrobiens dans le lait de brebis et de chèvre

  • Giraldo, J.
  • Cabizza R.
  • Sanz, D.
  • Mata, L.
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
[Otros] La présence de résidus d'antimicrobiens dans le lait représente un problème technologique pour la filière laitière et un risque pour la santé publique. De nombreuses méthodes ont été développées pour analyser les résidus d'antibiotiques dans le lait de vache, cependant ces méthodes ne fonctionnent pas toujours correctement avec le lait de brebis et de chèvre. Dans ce travail, nous présentons une évaluation sur la performance d'un nouveau système de dépistage de résidus d¿antibiotiques dans le lait de brebis et de chèvre. Le nouveau système combine un test d'inhibition microbienne (Eclipse Farm) et un dispositif (e-Reader) qui intègre une incubation à 65ºC et une surveillance continue du changement de la couleur du test. La performance du test a été validée conformément à la décision 2002/657/CE de la Commission Européenne. La sensibilité a été évaluée sur 12 molécules provenant de plusieurs familles d¿antimicrobiens. Dans tous les cas, les limites de détection calculées étaient proches aux limites autorisées (Limite Maximale de Résidus). Les capacités de détection (CCß) ont été également déterminées pour 7 molécules représentant les principaux groupes d¿antimicrobiens utilisés dans l'élevage laitier (pénicillines, céphalosporines, aminoglycosides, tétracyclines, sulfamides et macrolides). La plupart des molécules ont été détectées au niveau de la LMR. L¿Eclipse Farm combiné avec le e-Reader est donc un test à large spectre, qui permet de couvrir la détection d¿un nombre important de molécules d¿antimicrobiens dans le lait de brebis et de chèvre., [EN] The presence of antibiotic residues in milk is a concern due to technological and health reasons. Although many methods have been developed to analyse antibiotic residues in cow milk, such methods not always work correctly with sheep and goat¿s milk. Herein, we presented a study of the performance of a new system for the screening of antimicrobial residues in sheep and goat¿s milk. The method combines a microbial inhibitor test (Eclipse Farm) and a device (e-Reader) that integrates incubation at 65ºC and continuous monitoring of the colour change. The performance of the new system was validated according to the European Commission Decision 2002/657/EC. Sensitivity of the new system was evaluated on 12 molecules from several families of antimicrobials. The detection limits were close to the European maximum residue limits (MRL). Detection capabilities (CCß) were also determined for 7 molecules representing the main antimicrobial groups used in dairy husbandry (penicillins, cephalosporins, tetracyclins, sulphonamides and macrolides). Most of the molecules were detected at the MRL level. The Eclipse Farm coupled to e-Reader has shown to be a valuable tool for screening a broad-spectrum of antimicrobial residues in sheep and goat milk.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Antimicrobial activity in cheese whey as an indicator of antibiotic drug transfer from goat milk

  • Giraldo-Gómez, Jennifer
  • Althaus, Rafael Lisandro
  • Beltrán Martínez, Mª Carmen|||0000-0002-5335-2179
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
[EN] Raw goat milk spiked with antibiotics was coagulated with rennet, the whey separated and the transfer of 18 antibiotics from the milk to the whey was evaluated by estimating antimicrobial activity of the whey using microbial inhibitor tests. Antibiotic-free whey (negative whey) spiked with different antibiotics was used as a reference. The antimicrobial activity in whey from milk spiked with most b-lactam drugs was lower (0e40%) than that of the reference whey, suggesting that these antibiotics are mostly released from curd and transferred to the whey. However, for most non-b-lactam drugs, an 84e100% reduction in the relative antimicrobial activity in whey was obtained, indicating the higher susceptibility for retention in curd. The traceability of antibiotics through the cheese-making process will make it possible to determine whether control systems are required to prevent the negative implications of the presence of antibiotic drug residues in cheese and whey products., This work is part of the AGL-2013-45147-R funded by the Ministry of Science and Innovation (Madrid. Spain). The authors are grateful to Zeulab, S. L. (Zaragoza, Spain) for their support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Validation of a microbiological inhibition system based on Eclipse Farm 3G coupled with e-Reader to screening B-lactam and tetracycline antibiotics in goat&apos, s cheese whey, Validation d&apos, un système d&apos, inhibition microbiologique basé sur Eclipse Farm 3G couplé avec un lecteur e-Reader pour le dépistage des antibiotiques ß-lactam et tetracycline dans le lactosérum de fromage de chèvre

  • Giraldo, J.
  • Cabizza, R.
  • Mata, L.
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
[EN] The presence of antimicrobial residues in milk and dairy products could cause negative technological effects and represents a risk for consumer health. During the cheese-making process, antibiotics could be retained in curd or eliminated in whey to a greater or lesser extent. Whey is a by-product used in the manufacture of foodstuffs for human consumption and animal feeding and therefore, the presence of antibiotic residues in this product should be controlled. Thus, it is crucial to develop an analytical strategy to screen antibiotics in whey. A new system for screening antibiotics in raw milk was recently developed, in which a microbial inhibitor tube test (Eclipse Farm) and a device (e-Reader) are coupled. The new system allows the incubation of the test and a continuous monitoring of the test colour change. The aim of this work was to study the performance of the new system for the detection of ß-lactam and tetracycline residues in goat¿s cheese whey. A preliminary study demonstrated the necessity to include a one-hour diffusion period at room temperature. The performance was validated in agreement with European Commission Decision 2002/657/EC. Specificity of microbial test was evaluated by analysing one hundred and thirty whey samples. Results showed a low percentage of false-positive results. The detection limits for amoxicillin, benzilpenicillin, cephalexin and oxytetracycline in goat¿s cheese whey were calculated and the detection capabilities (CCß) were below or at the MRL levels, with the exception of amoxicillin, which was slightly above them. In conclusion, Eclipse Farm coupled to e-Reader represents an appropriate method to screen ß-lactams and tetracycline residues in whey., [Otros] La présence de résidus d'antibiotiques dans le lait et les produits laitiers peut entraîner des problèmes technologiques et un risque pour la santé des consommateurs. Pendant le processus de fabrication du fromage, les antibiotiques peuvent rester attachés au caillé ou peuvent être éliminés dans le sérum. Le lactosérum est un sous-produit utilisé dans la fabrication de denrées alimentaires destinées à la consommation humaine et à l'alimentation animale et, par conséquent, la présence de résidus d'antibiotiques dans ce produit doit être bien contrôlée. Il est donc essentiel de mettre en place une stratégie analytique pour l'analyse des antibiotiques dans le lactosérum. Un nouveau test d'inhibition microbienne (Eclipse Farm) couplé avec un dispositif d'incubation et de lecture (e-Reader) a été récemment développé pour le dépistage d'antibiotiques dans le lait cru. Le nouveau système permet l'incubation et la surveillance continue du changement de la couleur du test. L'objectif de ce travail consistait à étudier la performance du nouveau système pour la détection des résidus de ß-lactames et de tétracyclines dans le lactosérum du fromage de chèvre. Une étude préliminaire a démontré la nécessité d'inclure une étape de diffusion d'une heure à température ambiante. Le système a été validé conformément aux procédures décrites dans la décision 2002/657/CE de la Commission Européenne. La spécificité du test a été évaluée en analysant 130 échantillons de lactosérum. Les résultats ont montré un faible pourcentage de résultats faussement positifs. Les limites de détection pour l'amoxicilline, la benzilpenicilline, la céphalexine et l'oxytétracycline dans le lactosérum du fromage de chèvre ont été calculées, ainsi que les capacités de détection (CCß), toutes en dessous ou au même niveau que les Limites de Résidus Maximum (LRM), sauf pour l'amoxicilline, avec une limite légèrement supérieure. En conclusion, Eclipse Farm couplé à e-Reader représente une méthode appropriée pour la détection des résidus des ß-lactames et tétracyclines dans le lactosérum de chèvre.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Food safety margin assessment of antibiotics: Pasteurized goat&apos, s milk and fresh cheese

  • Quintanilla-Vázquez, Paloma Galicia
  • Doménech Antich, Eva Mª|||0000-0003-3560-6355
  • Escriche Roberto, Mª Isabel|||0000-0003-0180-0360
  • Beltrán Martínez, Mª Carmen|||0000-0002-5335-2179
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
[EN] Traces of antimicrobials in milk are of great concern for public health. The European Union has established maximum residue limits in milk; these, however, by themselves do not guarantee the absence of drug residues in milk and related products. Currently, very little information is available on the transfer of antibiotic residues from milk to other dairy products and their potential effect on food safety. This work evaluated the presence of antibiotic residues in pasteurized fluid milk and fresh cheeses from goat's milk containing these veterinary drugs at legal safety levels (maximum residue limits) and assessed the safety margin of these dairy products for consumers. Eight antibiotics (amoxicillin, benzylpenicillin, cloxacillin, neomycin, erythromycin, ciprofloxacin, enrofloxacin, and oxytetracycline) were selected, and three batches of fresh cheese were made from pasteurized goat's milk spiked with each of these drugs. Drug residues in milk and cheese samples were analyzed by liquid chromatography¿tandem mass spectrometry. The safety margin of goat's milk products was calculated taking into account different age groups (children, teenagers, and adults). Results showed that most antibiotics present in raw milk remained in pasteurized milk and were transferred to cheese to a high extent; retention was above 50% in most cases. The minimum safety margin in pasteurized milk was obtained for enrofloxacin, ciprofloxacin, and erythromycin for the children's group. For fresh cheese, an elevated safety margin was obtained for all antibiotics and age groups considered. However, the large amounts of antibiotics retained in the cheese might contribute to the development and spread of antimicrobial resistance. Considering the differences in milk from different species and the great variety of cheeses, it would be advisable to continue the traceability study of antibiotics in order to increase the safety margin of dairy products., This work is part of AGL-2013-45147-R, funded by the Ministry of Science and Innovation (Madrid, Spain). The authors thank Universitat Politecnica de Valencia (Program of Research and Development, FPI-2014) for funding the Ph.D. scholarship FPI-2014 attained by P. Quintanilla.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Interferences on microbial inhibitor tests related to ivermectin treatment in lactating dairy goats

  • Romero Rueda, Tamara
  • Moya, V.J.|||0000-0002-6769-0515
  • Fernández Martínez, Nemesio|||0000-0001-7150-2903
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
  • Althaus, Rafael Lisandro
  • Reybroeck, Wim
[EN] This Research Communication reports interferences related to the administration of ivermectin in lactating dairy goats on the response of microbial tests for screening antibiotics in milk. Twenty-eight Murciano-Granadina goats, naturally infested with Sarcoptes scabiei var. caprae, were treated with a subcutaneous injection of ivermectin (200 mu g/kg b.w.). To prevent re-infestation, a second dose was applied 7 d later. Individual milk samples were collected, daily, up to 15 d post-treatment. Milk samples were analysed by microbial inhibitor tests (BRT MRL, Delvotest SP-NT MCS and Eclipse 100) and ivermectin residues were quantified by HPLC. A large number of positive results were obtained for all microbial tests, especially on the first day after treatment (BRT MRL = 464%; Delvotest SP-NT MCS = 143%; and Eclipse 100 = 178%). However, the highest concentration of drug residues in milk (243 ng/ml) was detected on the tenth day after treatment, when positive outcomes were relatively lower (BRT MRL = 178%; Delvotest SP-NT MCS = 107%; and Eclipse 100 = 74%). Results herein suggest that factors related to the ivermectin treatment other than drug residues in milk, or alterations produced by the parasitic disease itself affecting the immune response of animals, could be the cause of false-positive results in microbial tests. It can be concluded that the application of ivermectin in dairy goats infested with sarcoptes mange during lactation produces persistent drug residues in milk, and could also cause false-positive results in microbial inhibitor tests for screening antibiotics., This work is part of the AGL-2009-11524 funded by the Ministry of Science and Innovation (Madrid, Spain) and the Generalitat Valenciana (ACOMOP/2012/164, Valencia, Spain).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Quinolones in goats&apos, milk: Effect on the cheese-making process, chemical and microbial characteristics of acid-coagulated cheeses

  • Beltrán Martínez, Mª Carmen|||0000-0002-5335-2179
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
  • Montes-Estellés, Rosa M|||0000-0002-4599-6644
  • Sanna, A.
  • Quintanilla, P.
[EN] The effect of the presence in goats' milk of enrofloxacin and ciprofloxacin on cheese-making and the characteristics of acid-coagulated cheeses was evaluated. Raw goats' milk was spiked with quinolones at maximum residue limit concentration (100 ¿g kg¿1). For each antibiotic, three batches of cheese were made by acid coagulation (pH 4.6) using a commercial starter culture. Cheese-making process, gross composition and microbial counts in the cheeses were unaffected by the presence of quinolones in milk. However, relatively high amounts of these substances were retained in the cheeses, with residual concentrations of 146.5 ± 4.9 ¿g kg¿1 and 150.7 ± 25.7 ¿g kg¿1 for enrofloxacin and ciprofloxacin, respectively, after 20 days of maturation. Results suggest that the use of goats' milk containing legally admissible amounts of enrofloxacin and/or ciprofloxacin would have no impact on cheese manufacturing, composition and microflora of acid-coagulated cheese. However, the transfer of these substances to the final products could compromise consumer safety., The authors are grateful for the financial support by the Ministerio de Ciencia e Innovacion (Madrid, Spain) project AGL-2013-45147-R.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Volatile profile of matured Tronchón cheese affected by oxytetracycline in raw goat milk

  • Quintanilla-Vázquez, Paloma Galicia
  • Hettinga, K.A.
  • Beltrán Martínez, Mª Carmen|||0000-0002-5335-2179
  • Escriche Roberto, Mª Isabel|||0000-0003-0180-0360
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
[EN] The presence of antibiotics in milk destined for cheese production may affect the biological processes responsible for the formation of volatile compounds, leading to alterations in the characteristic cheese flavor expected by consumers. The aim of this study was to evaluate the effect of the presence of oxytetracycline in goat milk on the volatile profile of ripened cheeses. Traditional mature Tronchón cheeses were manufactured from raw goat milk spiked with different concentrations of oxytetracycline (50, 100, and 200 ug/kg). Cheese made from antibiotic-free goat milk was used as control. We analyzed the residual amounts of the antibiotic and the volatile profile of the experimental cheeses on a fortnightly basis during maturation using liquid chromatography tandem mass spectrometry and then solid-phase microextraction followed by gas chromatography-mass spectrometry. Our results suggested that oxytetracycline was widely transferred from milk to cheese: drug concentrations in the cheeses were 3.5 to 4.3 times higher than those in raw milk. Although the residual amounts of oxytetracycline significantly decreased during maturation (88.8 to 96.5%), variable amounts of residues remained in cheese matured for 60 d (<10 to 79 ug/kg). In general, the presence of oxytetracycline in goat milk did not affect the volatile profile of Tronchón cheeses; volatile profile was significantly modified by ripening time. Still, the presence of oxytetracycline residues in cheeses ripened for 60 d could be of great concern for public health., This work is part of the AGL-2013-45147-R funded by the Ministry of Science and Innovation (Madrid. Spain). The authors thank the Research and Development Support Program, "Ayudas para movilidad dentro del Programa para la Formación de Personal Investigador" (2.016) of Universitat Politècnica de València (Spain), allowing Paloma Quintanilla to perform a predoctoral stay at the Food Quality and Design Group, Wageningen University and Research (Wageningen, the Netherlands). The authors state that they have no conflicts of interest.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Enrofloxacin Treatment on dairy goats: Presence of antibiotic in milk and impact of residue on technological process and characteristics of mature cheese

  • Quintanilla-Vázquez, Paloma Galicia
  • Beltrán Martínez, Mª Carmen|||0000-0002-5335-2179
  • Escriche Roberto, Mª Isabel|||0000-0003-0180-0360
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
[EN] Lately quinolones, particularly enrofloxacin, have been incorporated as a veterinary treatment of small ruminants, like goats, whose milk is highly appreciated for the manufacture of traditional cheeses. This study aims to evaluate the influence of the presence of enrofloxacin in milk (from goats previously treated with this antibiotic), on the characteristics (chemical composition; colour, texture, volatile profile and sensory evaluation) of mature cheese at 0, 30 and 60 days. Three batches of cheeses were made from milk obtained at three different times with respect to the animals¿ antibiotic administration (24 h before treatment, 24 h after treatment, and after the withdrawal period). The manufacture process of cheese is not affected by enrofloxacin in any way; therefore, it will remain unnoticed in the production line. A transfer of enrofloxacin, and its metabolite ciprofloxacin, to the cheese produced with milk obtained 24 h after treatment was observed. The presence of antibiotic residues does not produce significant changes in any of its compositional, texture and colour characteristics, when compared to the cheeses made before veterinary treatment with antibiotic-free milk, with the only exception of some compounds of the volatile fraction. Enrofloxacin and its metabolite show high stability during the cheese maturation (51% of both remain after 60 days of ripening). In general, the presence of this antibiotic has lesser effects on all the characteristics of the cheese compared to those modifications produced during the maturation time. Sensory measures of odour, colour, appearance and texture attributes, as well as the global preference, are also not affected by this antibiotic, which would imply a risk for the population since its presence would go undetected., This work is part of the AGL-2013-45147-R Project funded by Ministerio de Ciencia e Innovación (Madrid. Spain). P. Quintanilla thanks Universitat Politècnica de València for the grant received for the development of this work (PAID-2014, UPV).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Effect of the presence of neomycin in goat¿s milk on the making and characteristics of Tronchón chees, Effet de la présence de néomycine dans le lait de chèvre sur la fabrication et les caractéristiques du fromage Tronchón

  • Quintanilla-Vázquez, Paloma Galicia
  • Beltrán Martínez, Mª Carmen|||0000-0002-5335-2179
  • Peris Palau, Bernardo
  • Escriche Roberto, Mª Isabel|||0000-0003-0180-0360
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
[Otros] La présence de résidus d'antibiotiques dans les produits laitiers peut constituer un problème pour la santé publique et pour l'industrie laitière. Dans ce travail, nous avons évalué l'effet de la présence de néomycine dans le lait de chèvre sur la fabrication et les caractéristiques du fromage Tronchón. Les fromages ont été fabriqués, en double exemplaire, à partir du lait de chèvre cru sans antibiotiques et avec l'addition de néomycine à la limite maximale de résidu (1500 ug/kg). Nous avons étudié les changements dans les caractéristiques du fromage et la présence de résidus à différentes périodes de maturation (1, 30 et 60 jours). La durée du procédé de fabrication augmentait (48 ± 18 min) sous l'effet de la présence de néomycine dans le lait de chèvre. Concernant les caractéristiques du fromage, nous avons observé une diminution dans les valeurs de l'activité de l¿eau ainsi qu¿une réduction dans les concentrations d'acides gras libres et d'acides aminés libres dans les fromages avec l'antibiotique, en suggérant une activité biochimique mineure pendant la maturation. Nous avons aussi observé une plus grande légèreté, moins rougeur et une plus faible élasticité dans ce type de fromage. En plus, pendant la maturation, les concentrations de néomycine dans le fromage augmentaient 4,9 fois par rapport à la concentration initiale dans le lait, ce qui pourrait impliquer un risque pour la santé publique., [EN] Antibiotic residues in milk and dairy products are a potential problem for public health, and for the dairy industry. This study investigated the effect of the presence of neomycin in goat's milk on the production and characteristics of semi-hard Tronchón cheese. Cheeses were made, in duplicate, from raw goat's milk without antibiotics and with addition of neomycin at the Maximum Residue Limit (1500 ug/kg). Possible chan ges in the characteristics and the presence of antibiotic residues in the cheeses were evaluated at different time points along ripening (1, 30 and 60 days). Processing time was increased (48 ± 18 min) by the presence of neomycin in milk. Regarding cheeses, lower values of water activity as well as reduced free fatty acids and free amino-acid concentrations were detected in cheeses from milk with the antibiotic, suggesting a minor biochemical activity throughout ripening. Thus, a greater lightness and lower redness value were observed in this type of cheese, also presenting lower springiness. Moreover, high concentrations of neomycin were retained in the cheese and concentrated during ripening, leading to a concentration factor of 4.9, with respect to the initial concentration in the milk, potentially implying a risk to public health., This work is part of the AGL-2013-45147-R funded by the Ministry of Science and Innovation (Madrid. Spain). The authors thank the UPV (Program of Research and Development) for funding the PhD scholarship FPI-2014 attained by P. Quintanilla.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Transfer of antibiotics from goat&apos, s milk to rennet curd and whey fractions during cheese-making

  • Giraldo, Jennifer
  • Igualada, Carmen
  • Cabizza, Roberto
  • Althaus, Rafael Lisandro
  • Beltrán Martínez, Mª Carmen|||0000-0002-5335-2179
[EN] The transfer of 35 antibiotics from milk to curd and whey was evaluated. Cheeses were produced at laboratory scale, from antibiotic-free goat's milk spiked with different antibiotic concentrations between 0.25 and 4 times the Maximum Residue Limits established in milk. Drug concentrations in milk, curd and whey were analysed by UHPLC-HRMS. Results indicated that most antibiotics were mainly transferred from milk to whey (up to 85.9%), with retention percentages in the curd lower than 50%, except for ceftiofur (59.7%) and dicloxacillin (52.8%). In most cases, drug distribution was unaffected by the antibiotic concentration in milk and correlated significantly to the drug lipophilicity (Log P) for beta-lactams (R-2 = 0.54) and sulfonamides (R-2 = 0.62). When drug ionization was considered (Log D), improved correlation coefficients were obtained for macrolides (R-2 = 0.98). However, other factors besides the drug solubility should be considered to explain and predict the partitioning of antibiotics during cheese-making., This work was supported by the Ministry of Science and Innovation (Madrid. Spain) (No. AGL-2013-45147-R) .